TokenPost·
Roche, Hansoh Announce Cancer Drug Deal With Over $15 Billion in Potential Milestones
$15B
potential milestones
Hansoh will receive $400 million upfront and another $110 million on the collaboration’s first anniversary.
More news
- TokenPostDeFiChain (DFI) Jumps 31.74% in 15 Minutes to $0.000553
- TokenPostFrench AMF Warns of Unauthorized Crypto Asset and Service Offers
- TokenPostWells Fargo Sees U.S. Small Caps Under Pressure After 5.5% Drop
- Crypto BriefingNasdaq rises as AI and semiconductor stocks recover ahead of earnings
- TokenPostGTCFX Appoints Charbel Raffoul CEO After Naming New General Manager
- TokenPostCME Group Opens Uniswap Futures Trading on 24/7 Schedule